Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Preadmission use of benzodiazepines and stroke outcomes: the biostroke prospective cohort study

Abstract : We tested the hypothesis that stroke outcomes in patients with preadmission use of benzodiazepine are worse. In a prospective cohort study, we recruited patients with acute ischaemic stroke. Mortality, functional outcomes and cognition were evaluated at 8 and 90 days after stroke. 370 patients were included. 62 (18.5%) of the 336 remaining patients were treated with benzodiazepines when stroke occurred, and they did not receive any other psychotropic drug. The mortality rate was higher in benzodiazepines users than non-users at day 8 (2.2% vs 8.1%, p=0.034) and day 90 (8.1% vs 25.9%, p=0.0001). After controlling for baseline differences using propensity-score matching, only the difference in mortality rate at day 90 was of borderline of significance, with a matched OR of 3.93 (95% CI, 0.91 to 16.98). In propensity-score-adjusted cohort, this difference remained significant with a similar treatment effect size (adjusted OR, 3.50; 95% CI, 1.57 to 7.76). A higher rate of poor functional outcome at day 8 and day 90 defined bymodified Rankin scale (mRS) ≥2 or by theBarthel index (BI) <95 was found in benzodiazepines users. In propensity-score-adjusted cohort, only the difference in mRS≥2 at day 90 remained significant (adjusted OR, 1.89; 95% CI, 1.02 to 3.48). In survivors at day 8 and at day 90, there was no significant difference in cognitive evaluation. Our study has shown that preadmission use of benzodiazepines could be associated with increased post-stroke mortality at 90 days. These findings do not support a putative neuroprotective effect of γ-aminobutyric acidA NCT00763217.
Liste complète des métadonnées

Littérature citée [24 références]  Voir  Masquer  Télécharger

https://hal.univ-lille.fr/hal-02513589
Contributeur : Lilloa Université de Lille <>
Soumis le : mardi 24 mars 2020 - 10:36:53
Dernière modification le : mardi 22 septembre 2020 - 10:00:03
Archivage à long terme le : : jeudi 25 juin 2020 - 13:23:32

Fichier

e022720.full.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Licence


Distributed under a Creative Commons Paternité - Pas d'utilisation commerciale 4.0 International License

Identifiants

Collections

Citation

Olivier Colin, Julien Labreuche, Julie Deguil, Anne-Marie Mendyk, Valerie Deken, et al.. Preadmission use of benzodiazepines and stroke outcomes: the biostroke prospective cohort study. BMJ Open, BMJ Publishing Group, 2019, 9, pp.e022720. ⟨10.1136/bmjopen-2018-022720⟩. ⟨hal-02513589v2⟩

Partager

Métriques

Consultations de la notice

251

Téléchargements de fichiers

860